Lynda Charters

This one-day symposium on January 31, 2026, will bring together clinicians and experts at the University Eye Clinic in Mainz to discuss optic neuropathies and diagnostic trends.

James Tsai, MD, MBA, sheds light on what is in the offing for glaucoma specialists

James Tsai, MD, MBA, discusses his approaches given the wide diversity of patients in a major urban setting when awareness of glaucoma can range from highly educated patients to uninformed individuals.

Data estimates the prevalence of glaucoma currently is almost 50% higher than previously estimated and over 1.6 million individuals in the UK are estimated to have glaucoma by 2060.

Key clinical trial data and PDUFA dates in early 2026 focus on treatments for dry eye, AMD, and rare eye diseases.

The Swiss-designed phaco platform provides mobility, simplified workflows, and reduced surgical waste for cataract procedures, according to the company.

Patients underwent a full ophthalmologic examination that included optical coherence tomography (OCT), OCT angiography, and biometry.

“Remarkable” results were reportedly obtained with hypotony with hydroxypropyl methylcellulose.

Optoretinography is an emerging technology used to test light-evoked photoreceptor activity.

Researchers uncover a DNA repair mechanism in Greenland sharks that preserves their vision for centuries, offering insights into longevity and eye health.

A recent study reveals significant ocular complications from monkeypox, highlighting the need for enhanced eye health strategies in affected regions.

A recent study represents a step forward in investigations of the retinal layers as they are affected by glaucoma.

The letter noted the FDA is unable to approve the application for ONS-5010/LYTENAVA (bevacizumab-vikg) in its current form for the treatment of wet AMD, according to the company.

The novel system converts light into electrical signals to stimulate retinal cells.

Strategies for treatment intervals, drug selection, and patient expectations.

Panel examines drug mechanisms, patient factors, and strategies to optimize results.

The grading scales were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular CTCAE scale.

In the study, authors investigated the natural history of GA lesion incidence rates and analyzed potential risk factors for faster incidence of GA lesions.

This retrospective cohort study used a large US administrative claims database to identify patients with a diagnosis of seborrheic dermatitis from January 1, 2016, through June 30, 2022.

Emerging anti-VEGF agents offer enhanced durability and anatomic outcomes in retinal disease.

Cases show improved clarity, astigmatism masking, and versatility in complex eyes.

Earlier use of SLT, sustained-release drug delivery, and MIGS is reframing glaucoma care.